Update on European Medicines Agency Review of Lecanemab Marketing Authorization Application
Update on European Medicines Agency Review of Lecanemab Marketing Authorization Application
March 22, 2024
Eisai announced an update on the regulatory review process of lecanemab by the European Medicines Agency (EMA). Additional details can be found in a news release available on Eisai’s website.
